Long-term results of surgical techniques and procedures in men with benign prostatic hyperplasia

被引:7
|
作者
Metcalfe C. [1 ]
Poon K.S. [1 ]
机构
[1] Department of Urologic Sciences, University of British Columbia, Richmond, BC V7C 5L9
关键词
Adverse effects; Benign prostatic hyperplasia; Bladder neck contracture; BPH; CLP; Contact laser prostatectomy; HoLAP; HoLEP; Humans; Hybrid techniques; Induced necrosis; Laser therapy; Male; Methods; Minimally invasive methods; Mortality; Open simple prostatectomy; OSP; Photoselective vaporization of the prostate; Physiopathology; Postoperative complications; Prostate; Prostatectomy; PVP; Surgery; Surgical procedures; Transurethral holmium laser ablation of the prostate; Transurethral holmium laser enucleation of the prostate; Transurethral microwave thermotherapy; Transurethral needle ablation of the prostate; Transurethral resection of prostate; Transurethral vaporization of the prostate; Treatment outcome; TUMT; TUNA; TURP; TUVP;
D O I
10.1007/s11934-011-0193-1
中图分类号
学科分类号
摘要
Benign prostatic hyperplasia (BPH) is one of the most common conditions associated with the aging male. Surgical management of lower urinary tract symptoms attributed to BPH has progressed over time as urologic surgeons search for more innovative and less invasive forms of treatment. Transurethral resection of the prostate (TURP) has long been the "gold standard" to which all other forms of treatment are compared. There are several different methods of surgical treatment of BPH, including whole gland enucleation/intact removal, vaporization, and induction of necrosis with delayed reabsorption as well as hybrid techniques. As with any form of surgical intervention, long-term results define success. Long-term follow-up consists of examining overall efficacy with attention to associated adverse events. TURP has the luxury of the longest follow-up, while less invasive forms of treatment starting to acquire long-term data. There are several surgical options for BPH; newer methods do show promise, while the "gold standard" continues to demonstrate excellent surgical results. © 2011 Springer Science+Business Media, LLC.
引用
收藏
页码:265 / 273
页数:8
相关论文
共 50 条
  • [1] Long-term results of medical treatment in benign prostatic hyperplasia
    Kim, Chun Il
    Chang, Hyuk Soo
    Kim, Byoung Kun
    Park, Choal Hee
    UROLOGY, 2006, 68 (05) : 1015 - 1019
  • [2] Long-Term Risk of Dementia among Men with Benign Prostatic Hyperplasia
    Norgaard, Mette
    Horvath-Puho, Erzsebet
    Corraini, Priscila
    Henderson, Victor W.
    Sorensen, Henrik T.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 455 - 455
  • [3] Update on the use of finasteride in benign prostatic hyperplasia: Long-term results
    Nickel, JC
    Andersen, JT
    RECENT ADVANCES IN PROSTATE CANCER AND BPH, 1997, : 23 - 28
  • [4] Long-term results of microwave thermotherapy for symptomatic benign prostatic hyperplasia
    Tan, AH
    Nott, L
    Hardie, WR
    Chin, JL
    Denstedt, JD
    Razvi, H
    JOURNAL OF ENDOUROLOGY, 2005, 19 (10) : 1191 - 1195
  • [5] Techniques and long-term results of surgical procedures for BPH
    Reich, Oliver
    Gratzke, Christian
    Stief, Christian G.
    EUROPEAN UROLOGY, 2006, 49 (06) : 970 - 978
  • [6] Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia
    Chiou, RK
    Chen, WS
    Akbari, A
    Foley, S
    Lynch, B
    Taylor, RJ
    UROLOGY, 1996, 48 (04) : 589 - 593
  • [7] Transurethral hyperthermia for benign prostatic hyperplasia: Long term results
    Petrovich, Z
    Pike, MC
    Boyd, SD
    Jozsef, G
    Astrahan, MA
    Baert, L
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1996, 12 (05) : 595 - 606
  • [8] SURGICAL-MANAGEMENT FOR BENIGN PROSTATIC HYPERPLASIA - INDICATIONS, TECHNIQUES, AND RESULTS
    JANKNEGT, RA
    PROSTATE, 1989, : 79 - 93
  • [9] SURGICAL TECHNIQUES, BENIGN PROSTATIC HYPERPLASIA, PHYSIOLOGY
    HOHENFELLNER, M
    MUSCHTER, R
    AKTUELLE UROLOGIE, 1995, 26 : 99 - 99
  • [10] The long-term cost effectiveness of treatments for benign prostatic hyperplasia
    DiSantostefano, RL
    Biddle, AK
    Lavelle, JP
    PHARMACOECONOMICS, 2006, 24 (02) : 171 - 191